Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01429727

The "Virtual" Multicenter Spontaneous Coronary Artery Dissection (SCAD) Registry

The primary goal of this project is to describe the clinical and physiologic characteristics of Spontaneous Coronary Artery Dissections (SCAD) in order to increase awareness, understanding, treatment and prevention of a potentially fatal cardiovascular event.

This study will be a retrospective and prospective review of medical course and current health of men and women with SCAD.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location status: Recruiting

Location contact

Marysia S Tweet, M.D., M.S.

PRINCIPAL_INVESTIGATOR

Susan Milbrandt

CONTACT

[email protected]

507-266-3180

About this study

Spontaneous Coronary Artery Dissection (SCAD) is a relatively rare and poorly understood condition that has been reported to affect more women than men. The coronary arteries consist of three layers, and dissection occurs when two of these layers separate, enabling blood to flow into the space between the layers. As the blood accumulates, this can cause obstruction to normal blood flow within the heart, leading to chest pain, heart attack and even sudden death.

The medical community has much to learn about treatment and prevention of this potentially fatal cardiovascular event. Mayo Clinic is conducting two studies of SCAD. This study consists of building a database/registry of patients with SCAD (whether they have been patients at Mayo Clinic or not) to identify patterns of SCAD incidence, causes and associations that could guide future research. With participant consent, Mayo Clinic staff will request a copy of the original coronary angiogram when SCAD was diagnosed to confirm the diagnosis and determine eligibility. If eligible, study coordinators will contact the participant to provide more information about the studies and request a signed informed consent document.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals who have been cared for at Mayo Clinic with a diagnosis of SCAD
  • SCAD in women who are pregnant or within 12 months postpartum at the time of SCAD
  • SCAD in individuals who self-identify as a member of a racial or ethnic group that is currently underrepresented in the registry. This would include anyone who identifies as: Black/African American, Asian, American Indian or Alaska Native, Native Hawaiian or Other Pacific Islander, and any race with Hispanic ethnicity
  • SCAD in a man
  • SCAD in persons younger than 30 years of age
  • SCAD within the past 2 weeks (acute)
  • SCAD patient enrolling into any other Mayo Clinic SCAD Research Study
  • SCAD in individuals who have a relative that has had a SCAD event

Persons with history of SCAD who are interested in participating in the study but do not meet the updated inclusion criteria will not be enrolled at this time. However, they will be given the option to share their contact information in order to be invited to future Mayo Clinic SCAD studies.

Treatment and study plan

Primary outcomes

  1. Descriptive Data

    Time frame: Continuous time frame following index event for 2-10 years from study contact date.

    Obtain data regarding SCAD related risk factors, presenting characteristics, treatments and long term outcomes.

Secondary outcomes

  1. Physical Health Update

    Time frame: Continuous time frame following index event for 2-10 years from study contact date.

    Record update on patient's current physical health and any relevant health events that may have occurred since the initial SCAD event.

  2. Mental Health Update

    Time frame: Continuous time frame following index event for 2-10 years from study contact date.

    Record update on patient's current mental health status since the initial SCAD event.

Study contacts

Contact information is provided by the study sponsor or research team.

Susan Milbrandt

CONTACT

[email protected]

507-266-3180

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Acronym: SCAD

Important dates

Study start
2011
Primary completion
2030
Study completion
2030
First posted
Sep 7, 2011
Registry last updated
Jan 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.